Radiomic analysis of computed tomography scans in COPD patients relates to different clinical and biological features, and identifies different lung function trajectories during follow-up.
Authors
Affiliations (8)
Affiliations (8)
- Institut de Salud Global de Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red (CIBER) en Epidemiología y Salud Pública, Madrid, Spain.
- A. Cáceres and A. Agustí contributed equally to this article as first authors.
- Universitat de Barcelona, Barcelona, Spain.
- Pulmonary Service, Respiratory Institute, Clinic Barcelona, Barcelona, Spain.
- Fundació Clinic per la Recerca Biomèdica - Institut d'Investigacions biomèdiques August Pi Sunyer, Barcelona, Spain.
- CIBER Enfermedades Respiratorias, Madrid, Spain.
- R. Faner and J.R. González contributed equally to this article as senior authors.
Abstract
COPD is a heterogeneous condition characterised by persistent, poorly reversible airflow obstruction. While some patients experience accelerated decline in forced expiratory volume in 1 s (FEV<sub>1</sub>), others remain stable. We hypothesised that unsupervised analysis of chest computed tomography (CT) scans using machine learning-derived radiomic features may identify endophenotypes associated with distinct clinical and biological characteristics and FEV<sub>1</sub> decline trajectories. We analysed 101 radiomic features from 1759 chest CT scans of COPD patients in the ECLIPSE study. Unsupervised consensus clustering identified six mutually exclusive radiomic clusters, and we derived six corresponding average patient score clusters (APSC1-6). Random coefficient models assessed associations between each APSC and baseline clinical characteristics, FEV<sub>1</sub> and its 3-year change, adjusting for relevant covariates. Associations with baseline gene expression in sputum and blood were also evaluated. Radiomic scores were associated with multiple baseline clinical features. Higher APSC2 (-5.3 mL·year<sup>-1</sup>; 95% CI -9.5- -1.0; p=0.01) and APSC6 (-5.5 mL·year<sup>-1</sup>; 95% CI -9.6- -1.3; p=0.01) predicted greater FEV<sub>1</sub> decline, whereas higher APSC3 was associated with slower decline (+5.2 mL·year<sup>-1</sup>; 95% CI 0.8-9.6; p=0.02). APSC6 was associated with increased sputum expression of genes enriched in respiratory infection pathways, relevant COPD loci such as <i>TRIM38</i> and <i>IFIT3</i>, and higher blood neutrophil counts. Unsupervised CT radiomic analysis identifies distinct COPD endophenotypes associated with variability in FEV<sub>1</sub> decline and biological markers, supporting potential stratified treatment.